
Journal of Medicinal Chemistry p. 357 - 366 (1987)
Update date:2022-08-04
Topics:
Lunt, Edward
Newton, Christopher G.
Smith, Christopher
Stevens, Graham P.
Stevens, Malcolm F. G.
et al.
The systematic variation of the potent antitumor agent mitozolomide (1) is extended to cover alteration of substituents at position 6 and 8 and to change the imidazo<5,1-d>-1,2,3,5-tetrazinone (6) skeleton to the isomeric pyrazolo<5,1-d>-1,2,3,5-tetrazino
View MoreTianjin Realet Chemical Technology Co.,Ltd.
website:http://www.realetchem.com
Contact:+86-022-58788819
Address:shuanggang industrial park
ShangHai Ruiyi Medical Technology Co.,Ltd.
Contact:+86-21-54718086
Address:No951 Jianchuan RD,Minhang District
Zhejiang Kente Chemical Co.,Ltd.
Contact:86-0576-87651912
Address:No.7, Fengxi West Road, Modern Industrial Zone
Contact:+86-18653358619
Address:zibo
Dongtai Xinyuan Chemical Co., Ltd.
Contact:+86-21-56733000
Address:404F, 99Nong No.117 Zhongtan Rd. Shanghai
Doi:10.1021/acs.orglett.7b03509
(2018)Doi:10.1021/ja00328a031
(1984)Doi:10.1021/ol061123c
(2006)Doi:10.1016/0040-4039(91)80043-6
(1991)Doi:10.1039/b605498f
(2006)Doi:10.1007/BF00515636
(1984)